New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.

  • November 10, 2025

Share

Original Source(s)

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

  • November 10, 2025

Related Content

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

  • by

  • September 4, 2026

  • 4 min
CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Toward Precision Cardio-Oncology in Breast Radiotherapy